111 Capital Makes New $1.03 Million Investment in Agilent Technologies, Inc. $A

111 Capital acquired a new position in Agilent Technologies, Inc. (NYSE:A) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 7,560 shares of the medical research company’s stock, valued at approximately $1,029,000.

A number of other large investors have also modified their holdings of the company. Massachusetts Financial Services Co. MA raised its position in shares of Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after purchasing an additional 433,342 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after purchasing an additional 25,139 shares during the last quarter. Generation Investment Management LLP raised its position in shares of Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after purchasing an additional 582,093 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Agilent Technologies in the fourth quarter worth approximately $549,158,000.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Barclays lifted their price target on Agilent Technologies from $140.00 to $145.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Robert W. Baird lifted their price target on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Wells Fargo & Company lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target on the stock. Finally, HSBC lowered their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $161.71.

Agilent Technologies Trading Down 2.1%

Shares of Agilent Technologies stock opened at $135.51 on Friday. The stock has a market cap of $38.27 billion, a P/E ratio of 27.21, a P/E/G ratio of 2.46 and a beta of 1.26. The stock’s 50 day simple moving average is $118.35 and its 200-day simple moving average is $128.35. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.84 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.99 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.